The haemophilia treatment landscape is fast evolving, with many new and innovative therapies in the final stages of development or being marketed in Europe. To help our members navigate these changes, the EHC has developed a publication, the New Product Review, issued twice a year with the latest therapeutic developments. The New Product Review Committee members support EHC staff in developing the content of this newsletter.
This committee is composed of:
University College London, UK
Queen’s University, Canada
Chair, EHC MAG, UK
EHC President, Irish NMO
EHC MASAG member, Irish NMO
Canadian Haemophilia Society
EHC MAG, Italy
Queen Mary University of London, UK
In addition to these volunteers, the New Product Review is also edited by some EHC MAG and MASAG members.
The work of this committee is supported by Laura Savini, EHC Communications and Public Policy Officer.